These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28146245)

  • 1. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
    Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
    JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time.
    Haak CS; Farinelli WA; Tam J; Doukas AG; Anderson RR; Haedersdal M
    Lasers Surg Med; 2012 Dec; 44(10):787-95. PubMed ID: 23212624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration.
    Haak CS; Christiansen K; Erlendsson AM; Taudorf EH; Thaysen-Petersen D; Wulf HC; Haedersdal M
    J Photochem Photobiol B; 2016 Jun; 159():42-8. PubMed ID: 27016718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL).
    Haedersdal M; Sakamoto FH; Farinelli WA; Doukas AG; Tam J; Anderson RR
    Lasers Surg Med; 2014 Aug; 46(6):462-9. PubMed ID: 24842112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermo-Mechanical Fractional Injury Enhances Skin Surface- and Epidermis- Protoporphyrin IX Fluorescence: Comparison of 5-Aminolevulinic Acid in Cream and Gel Vehicles.
    Foged C; Haedersdal M; Bik L; Dierickx C; Phillipsen PA; Togsverd-Bo K
    Lasers Surg Med; 2021 Jul; 53(5):622-629. PubMed ID: 33001491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
    van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
    Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term chemical pretreatment cannot replace curettage in photodynamic therapy.
    Nissen CV; Wiegell SR; Philipsen PA; Wulf HC
    Photodermatol Photoimmunol Photomed; 2016 May; 32(3):146-52. PubMed ID: 26868849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short incubation fractional CO
    Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy.
    Gerritsen MJ; Smits T; Kleinpenning MM; van de Kerkhof PC; van Erp PE
    Dermatology; 2009; 218(3):193-202. PubMed ID: 19077380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
    Togsverd-Bo K; Lerche CM; Philipsen PA; Poulsen T; Wulf HC; Haedersdal M
    Exp Dermatol; 2012 Apr; 21(4):260-4. PubMed ID: 22320713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
    Tyrrell J; Campbell SM; Curnow A
    Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
    Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
    Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
    Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin surface Protoporphyrin IX fluorescence is associated with epidermal but not dermal fluorescence intensities.
    Foged C; Philipsen PA; Wulf HC; Haedersdal M; Togsverd-Bo K
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101681. PubMed ID: 32032781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.
    Lerche CM; Fabricius S; Philipsen PA; Wulf HC
    Photochem Photobiol Sci; 2015 May; 14(5):875-82. PubMed ID: 25812618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.